| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,342 |
8,762 |
$1.22M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,831 |
1,016 |
$292K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,292 |
2,792 |
$260K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,437 |
5,657 |
$259K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,312 |
737 |
$144K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,611 |
2,001 |
$136K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,532 |
2,312 |
$103K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,604 |
942 |
$96K |
| 71045 |
Radiologic examination, chest; single view |
7,276 |
3,633 |
$91K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
644 |
579 |
$76K |
| 80053 |
Comprehensive metabolic panel |
8,339 |
6,476 |
$61K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,977 |
2,222 |
$56K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,975 |
3,400 |
$50K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,314 |
245 |
$50K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
425 |
100 |
$49K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,015 |
6,710 |
$48K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,640 |
2,716 |
$45K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
304 |
177 |
$23K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
140 |
83 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,543 |
1,442 |
$19K |
| 82607 |
|
1,507 |
1,369 |
$18K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
145 |
128 |
$18K |
| 71046 |
Radiologic examination, chest; 2 views |
919 |
502 |
$17K |
| 82746 |
|
1,444 |
1,306 |
$17K |
| 80061 |
Lipid panel |
1,571 |
1,369 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
5,902 |
4,325 |
$15K |
| 87088 |
|
2,282 |
1,867 |
$13K |
| 83880 |
|
595 |
489 |
$12K |
| 84484 |
|
1,671 |
1,279 |
$12K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
504 |
417 |
$11K |
| 83735 |
|
2,072 |
1,802 |
$9K |
| 80306 |
|
708 |
597 |
$8K |
| 81001 |
|
3,748 |
3,077 |
$7K |
| 87430 |
|
556 |
460 |
$6K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,262 |
933 |
$6K |
| 82728 |
|
518 |
478 |
$6K |
| 84439 |
|
756 |
680 |
$5K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
18 |
12 |
$5K |
| 87186 |
|
806 |
586 |
$5K |
| 87077 |
|
854 |
664 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
201 |
180 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
134 |
105 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
606 |
548 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
43 |
37 |
$4K |
| 83550 |
|
530 |
487 |
$4K |
| 81025 |
|
640 |
539 |
$4K |
| 87807 |
|
289 |
262 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
404 |
266 |
$3K |
| 83540 |
|
537 |
494 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
176 |
133 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
33 |
24 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
65 |
62 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
65 |
62 |
$2K |
| 93880 |
|
31 |
16 |
$2K |
| 86738 |
|
122 |
109 |
$1K |
| 93925 |
|
19 |
12 |
$1K |
| 83690 |
|
153 |
130 |
$668.44 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
32 |
32 |
$663.32 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
31 |
27 |
$547.90 |
| 82553 |
|
49 |
28 |
$363.81 |
| 85651 |
|
96 |
89 |
$325.88 |
| 82550 |
|
77 |
52 |
$312.90 |
| 83605 |
|
45 |
26 |
$220.78 |
| 84153 |
|
13 |
13 |
$215.15 |
| 86308 |
|
37 |
35 |
$151.74 |
| 82948 |
|
36 |
14 |
$129.78 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,294 |
1,033 |
$51.80 |
| 84550 |
|
13 |
13 |
$49.91 |
| J3490 |
Unclassified drugs |
64 |
26 |
$13.65 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
488 |
298 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
322 |
276 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
148 |
94 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
101 |
96 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
126 |
99 |
$0.00 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
22 |
22 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
34 |
32 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
17 |
12 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
635 |
462 |
$0.00 |